Document is current
Any future updates will be listed below
-
Authors
Netsch, P.
Elvers-Hornung, S.
Uhlig, S.
Klüter, H.
Huck, V.
Kirschhöfer, F.
Brenner-Weiß, G.
Janetzko, K.
Solz, H.
Wuchter, P.
Bugert, P.
Bieback, K. https://orcid.org/0000-0003-2621-0703
-
Funding
Funding for this research was provided by:
Helmholtz-Gemeinschaft (BioInterfaces in Technology and Medicine (BIFTM) of the Karlsruhe Institute of Technology (KIT))
Deutsche Forschungsgemeinschaft (Open Access Publishing, by the Baden-Württemberg Ministry of Science, Research and the Arts and by Ruprecht-Karls-Universität Heidelberg)
- License Information
-
More Information
Article History
Received: 9 March 2018
Revised: 8 June 2018
Accepted: 19 June 2018
First Online: 4 July 2018
Ethics approval and consent to participate
: Platelet donors were volunteer healthy persons giving informed consent, who had not been taking any platelet inhibiting medication for at least 2 weeks. The Mannheim Ethics Commission II confirmed that the regular blood donor questionnaire and informed consent documentation waives the need for ethical approval.MSC experiments were approved by the Mannheim Ethics Commission II (vote numbers 2010-262 N-MA, 2009-210 N-MA, 49/05 and 48/05).
: Not applicable.
: PW receives honoraria from and has membership on Advisory Boards for Sanofi-Aventis. The remaining authors declare that they have no competing interests.
: Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
